SCHEMBL1751982

SCHEMBL1751982

O=S(O)S.[NaH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL5047482 0.95 CA1 (0.46)
Water SCHEMBL8011320 0.95 CA1 (0.46)
SCHEMBL56797 0.94
SCHEMBL6549037 0.89
Ammonia Solution, Strong SCHEMBL4303203 0.89
Ammonia Solution, Strong SCHEMBL4303198 0.89
Methane SCHEMBL12986165 0.89
SCHEMBL7056397 0.89
Ammonia Solution, Strong SCHEMBL4368298 0.84
Sulfurous Acid SCHEMBL8349231 0.76 CA1 (0.86)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117322585-A Soup formula for pickling small intestines 福建好柒吖食品有限公司 2024-01-02 CN claimed
WO-2011101704-A1 PROCESS FOR PREPARING (4S, 6S)-4-(ETHYLAMINO)-5,6-DIHYDRO-6-METHYL-4H-THIENO-[2,3-B]THIOPYRAN-2-SULFONAMIDE-7,7-DIOXIDE AND ITS INTERMEDIATES MICRO LABS LIMITED (IN) 2011-08-25 WO claimed
EP-3909572-B1 STABLE PRESERVATIVE-FREE MYDRIATIC AND ANTI-INFLAMMATORY SOLUTIONS FOR INJECTION RAYNER SURGICAL IRELAND LTD (IE) 2025-08-06 EP disclosed
EP-3983393-B1 NOVEL SPIROBICYCLIC INTERMEDIATES JANSSEN PHARMACEUTICA NV (BE) 2025-04-02 EP disclosed
US-20250032452-A1 STABLE PRESERVATIVE-FREE MYDRIATIC AND ANTI-INFLAMMATORY SOLUTIONS FOR INJECTION RAYNER INTRAOCULAR LENSES LIMITED (GB) 2025-01-30 US disclosed
US-20240398760-A1 CHELATED, STABLE OPHTHALMOLOGICAL COMPOSITIONS OF KETOROLAC AND PHENYLEPHRINE AND APPLICATIONS THEREOF SOMERSET THERAPEUTICS, LLC 2024-12-05 US disclosed
US-12156868-B2 Formulations of pilocarpine and brimonidine compounds and related methods SOMERSET THERAPEUTICS, LLC (US) 2024-12-03 US disclosed
US-12145961-B2 Spirobicyclic analogues JANSSEN PHARMACEUTICA NV (BE) 2024-11-19 US disclosed
US-12133842-B2 Stable preservative-free mydriatic and anti-inflammatory solutions for injection RAYNER INTRAOCULAR LENSES LIMITED (GB) 2024-11-05 US disclosed
US-12102632-B2 Quinolone dispersions SOMERSET THERAPEUTICS, LLC (US) 2024-10-01 US disclosed
US-12064440-B2 Ophthalmic gel compositions of bimatoprost and timolol and associated methods SOMERSET THERAPEUTICS, LLC (US) 2024-08-20 US disclosed
EP-0477772-A1 Photographic silver halide materials ILFORD Limited (GB) 1992-04-01 EP disclosed
EP-0354622-A1 Oxadiazolone herbicides SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1990-02-14 EP disclosed
US-4748097-A Method of preparing a hologram CIBA-GEIGY AG (CH) 1988-05-31 US disclosed
EP-0207001-A2 Method of preparing a hologram ILFORD Limited (GB) 1986-12-30 EP disclosed
US-4536595-A Process for the preparation of alpha-aryl-propionic acids and alkaline salts thereof MONTEDISON S.P.A. (IT) 1985-08-20 US disclosed
EP-0076722-B1 PROCESS FOR THE PREPARATION OF ALPHA-ARYL-PROPIONIC ACIDS AND THEIR ALKALINE SALTS Montedison S.p.A. (IT) 1985-02-20 EP disclosed
EP-0076722-A1 Process for the preparation of alpha-aryl-propionic acids and their alkaline salts Montedison S.p.A. (IT) 1983-04-13 EP disclosed
US-4110534-A PROCESS FOR THE PREPARATION OF 3-VINYL AND SUBSTITUTED VINYL CEPHALOSPORINS GLAXO LABORATORIES LIMITED (GB) 1978-08-29 US disclosed
US-4107431-A ANTIBIOTICS GLAXO LABORATORIES LIMITED (GB) 1978-08-15 US disclosed